Responsible for US Commercial Insights, Brand Analytics and Sales Force Effectiveness for the Specialty & Rare Disease Business Unit.

o Lead 13 person cross-functional team across forecasting, analytics, and market research.o Partner with the Commercial Operations, GIACE, Brand, Sales and Market Access teams to support the Respiratory Biologics Therapeutic Area franchise to drive the full commercial value of the portfolio ($2B revenue).o Collaborate to shape brand strategy and performance assessment through proactive thought-leadership, identification of and answering key business questions, ensuring robust forecast models, and incorporating external perspectives.o Collaborate with the top 8 markets to align on forecasts, KPIs, key reported metrics, and to pull through key strategic opportunities.

o Led 10 person cross-functional team across data, analytics, and advanced analytics.o Partner with the Commercial Operations, GIACE, Brand, Sales and Market Access teams to support the Respiratory Biologics Therapeutic Area franchise to drive the full commercial value of the portfolio ($1B revenue).o Led the creation of a cloud-based patient-centric claims environment which was used as the organization’s central data hub for data and insights.o Responsible for targeting and behavioral segmentation efforts used to guide sales force efforts and omni-channel approach in Severe Uncontrolled Asthma. o Insource a significant amount of advanced analytics work, which was historically created via external vendors (3MUSD per year in managed services cost saved).

o Led development of business cases to support late-stage development and commercial investment decisions.o Develop global activities for pre-launch including disease awareness and launch preparation plans.o Engage with regions and key markets to ensure launch readiness / commercial excellence.

o Led 12 person cross-functional team with a P&L of 43MUSD across sales and sales enablement for the companies top strategic clients.o Managed a team responsible for vendors, client research, RFI/RFP responses, and funnel forecasting.o Led the analytics team to created automated solutions that optimize sales efforts: o a CRM embedded solution to predict expected revenue and identify potential risk.o an "in-flight" lead scoring solution that provided a 48% improvement in sales effectiveness and provided an ROI of our effortso a new client process that uses client analogs to inform finance and gauge risko a customer engagement solution that used NLP and modeling to assess the overall customer experience and provide recommendations to prevent churn

o Led market development activities for SAS Health & Life Sciences, with focus on integrated analytics and marketing solutions for biopharmaceutical organizations. o Led consulting engagement with pharmaceutical, provider and payor organizations. o Organized thought leadership engagements both internally and externally focused on industry trends affecting payor, provider, and pharmaceutical organizations. o Managed teams of individuals focused on creating industry solutions to create unique offerings in the health and life science market. o Provided strategic consultation on topics such as: real-world evidence, marketing analytics, commercial analytics, maximizing product launch value, revenue cycle management, machine learning, artificial intelligence, predictive analytics and big data. o Managed sales and strategy for some of SAS' largest customers with market cap in excess of $220B (closed 5-year deals in excess of 70MUSD in gross revenue).

o Created and managed the company-wide analytic strategy and capabilities for all product and cross-product offerings.o Established a differentiated set of products in the market that can drive direct analytical revenue and sale of entire suite of products.o Using a combination of SQL, SQL reporting and Tableau, lead the development of reporting and BI capabilities, which allowed for quick expansion of standard product analytics to clients at all levels of the organizations. o Created analytic modeling capabilities with initial focus in the area of increasing hospital collections, patient charity and coordination of benefits. o Developed provider-focused solutions which were used to reduce rejected claims. o Established ROI tools that were used to illustrate the value of each product line.o Developed the hospital targeting and territory structure used to integrate the sales forces for Passport Health and Experian after mergers and acquisitions. o Designed the territory goals for recently acquired organizations and field forces.

o Managed 5 teams to help address business opportunities across six product lines and four therapeutic areas. o Managed and created advanced analytics insights to drive strategic product planning, targeting, goal setting and forecasting. o Developed custom predictive tools across the entire portfolio to assess future product performance and incremental impact of future tactical initiatives. o Designed quantitative models which were used to scenario plan and assess potential risks to annual financial targets. o Created predictive outcomes model which was used to assess the likelihood that a new product launch will meet expected financial levels as well as to provide executive leadership with corrective action needed to address the financial gap. o Advised leadership regarding sales force sizing and placement scenarios based on managed care coverage, competitive landscape and physician product acceptance.

o Oversaw the development of forecasts for the entire in-line and future UCB portfolio. o Managed the development and implementation of all forecasts, market research and strategic insight for new business development projects.o Consulted on the development and implementation of advanced analytical models used to access the future impact of field force promotion levels, sampling levels and new product indications.o Led external projects with an annual budget of approximately 1 million USD in the areas of field force optimization, quantitative and qualitative market research and new product forecast. o Acted as an internal consultant to C-Suite and executive leadership for numerous US and Global strategic projects focused on future product line extensions and future product launches. o Key liaison between UCB and all co-promote partners (Pfizer, Sanofi-Aventis and Teva) for all forecasting and advanced analytics projects. o Identified by Global leadership to take part in a year-long Executive Leadership Program.

o Created forecast for entire Solvay product portfolio.o Designed analytical models to access the portfolio impact of increasing/reducing sales force promotion, sampling and impact of adding additional product to current portfolio. o Developed the financial business case for numerous new business development projects. o Liaison between Solvay and all co-promote partners (Pfizer, Wyeth and Abbott) for forecasting and advanced analytics projects. o Created training material and trained the analytics department regarding statistical modeling.

o Taught 2 statistics courses per semester.

o Lead statistician for 3 pivotal asthma trials and for the Integrated Summary of Efficacy.o Constructed an analytical risk assessment used to gauge subject recruitment levels for pivotal trials. o Work closely with the Data Management department in organizing databases and verifying the integrity of data from clinical studies.o Work closely with the clinical team in reviewing protocols, and writing and reviewing clinical/statistical summaries. o Consulted with product strategy teams to develop a target list of customers.o Measured ROI for numerous multi-wave promotion activities.o Analyzed sales trends to develop actionable business decisions. o Developed time-to-purchase models for key brands.o Worked on survey projects involving multivariate data analysis and large-scale variable reduction.

o Two summer internships loading data and building default models for large financial institutions.